Cancer in Scotland: Action for Change set a target that "the maximum wait from urgent referral to treatment for all cancers will be two months"
Urology - period of diagnosis: 1 January to 31 March 2007
Area of diagnosis | Number of eligible urgent referrals* | Number treated within 2 months (62 days) of referral | % compliance with 2 month urgent referral to treatment target | Minimum wait (Days) | Maximum wait (Days) | Median wait (Days) | 90th Percentile (Days) |
| | | | | | | |
Scotland | 254 | 186 | 73.2% | 0 | 220 | 43 | 93 |
| | | | | | | |
NOSCAN | 75 | 56 | 74.7% | 1 | 201 | 45 | 94 |
Argyll & Clyde (Highland) | - | - | n/a | n/a | n/a | n/a | n/a |
Grampian | 27 | 22 | 81.5% | 2 | 167 | 45 | 96 |
Highland | 18 | 9 | 50.0% | 14 | 110 | 62 | 106 |
Orkney | - | - | n/a | n/a | n/a | n/a | n/a |
Shetland | - | - | n/a | n/a | n/a | n/a | n/a |
Tayside | 28 | 23 | 82.1% | 1 | 201 | 37 | 95 |
Western Isles | 2 | 2 | 100.0% | 29 | 49 | n/a | n/a |
| | | | | | | |
SCAN | 61 | 38 | 62.3% | 3 | 149 | 52 | 97 |
Borders | 6 | 3 | 50.0% | 5 | 149 | 64 | n/a |
Dumfries & Galloway | 6 | 4 | 66.7% | 8 | 64 | 29 | n/a |
Fife | 18 | 13 | 72.2% | 3 | 104 | 42 | 95 |
Lothian | 31 | 18 | 58.1% | 3 | 119 | 59 | 96 |
| | | | | | | |
WOSCAN | 118 | 92 | 78.0% | 0 | 220 | 38 | 89 |
Argyll & Clyde (Greater Glasgow) | 16 | 13 | 81.3% | 5 | 79 | 17 | 69 |
Ayrshire & Arran | 14 | 13 | 92.9% | 0 | 68 | 33 | 65 |
Forth Valley | 16 | 13 | 81.3% | 1 | 117 | 40 | 88 |
Lanarkshire | 23 | 9 | 39.1% | 8 | 220 | 71 | 127 |
Greater Glasgow | 49 | 44 | 89.8% | 1 | 141 | 40 | 60 |
*Exclusion categories are: died prior to receiving treatment, refused treatment, patient induced non-clinical delay, co-morbidities, clinical reasons and initially referred to another non-cancer specialty.
n/a: Not applicable due to small numbers
Cancer waiting times statistics are subject to a programme of quality improvement focusing on consistency and coverage.
These improvements need to be taken in to account when making comparisons on quarter on quarter performance.